Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 275 publications
Overcoming barriers to neurosurgical care with technology and innovation.
Journal: BMC global and public health
Published: February 15, 2026
A Decade of Insights From New Graduate Physiotherapists on a Large Statewide Transition to Practice Program: A Repeated Cross-Sectional Survey Study.
Journal: Health science reports
Published: December 12, 2025
Low-Energy Dipole Strength Distribution in ^{102}Ru: Coexistence of Scissors and Octupole Resonances.
Journal: Physical review letters
Published: October 24, 2025
Hybridization capture sequencing for Vibrio spp. and associated virulence factors.
Journal: mBio
Published: June 25, 2025
Worldwide procedural variations of primary percutaneous coronary intervention for ST-elevation myocardial infarction: Insights from the "Stent - Save a Life!" initiative.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: June 24, 2025
Worldwide procedural variations of primary percutaneous coronary intervention for ST-elevation myocardial infarction: Insights from the "Stent - Save a Life!" initiative.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: June 24, 2025
Endothelial Cell Organization Drives Distinct Agonist-Specific Ca2+ Dynamics in Arteries and Veins.
Journal: Acta physiologica (Oxford, England)
Published: April 08, 2025
Engineering Chinese Hamster Ovary Cells to Mitigate Polysorbate Degradation in Biotherapeutics.
Journal: Biotechnology and bioengineering
Published: February 17, 2025
Exploring Antimycobacterial Potential: Safety Evaluation and Active Compound Isolation from Gymnopilus junonius.
Journal: Antibiotics (Basel, Switzerland)
Published: December 31, 2024
Evidence for I2 loss from the perovskite-gas interface upon light-induced halide segregation.
Journal: Chemical science
Published: November 28, 2024
Toripalimab in combination with HBM4003, an anti-CTLA-4 heavy chain-only antibody, in advanced melanoma and other solid tumors: an open-label phase I trial.
Journal: Journal for immunotherapy of cancer
Published: September 08, 2024
Last Updated: 09/26/2026